Department of Pathophysiology and Transplantation, Università degli Studi, Foundation IRCCS, Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
European Institute of Dermatology, Milan, Italy.
J Infect Dev Ctries. 2023 May 31;17(5):713-715. doi: 10.3855/jidc.17750.
Reports of permethrin resistance of Sarcoptes scabiei var. hominis are emerging. We propose that this may be pseudoresistance. The resistance is due to inadequate counselling by physicians, incorrect treatment (insufficient quantity of permethrin; too short length of treatment), and poor adherence and compliance by patients. Other reasons include single application of permethrin, suggestion to apply the drug for 6-8 hours, failed application on subungual folds, irritant contact dermatitis, in particular on genitals, for which some patients stop the treatment, and unexplainable use of permethrin in post-scabies prurigo. Thus, we believe that several cases of resistance to permethrin are actually cases of pseudoresistance.
疥疮蠕形螨的氯菊酯耐药性报告正在出现。我们认为这可能是假性耐药。耐药性是由于医生提供的咨询不足、治疗不当(氯菊酯用量不足;治疗时间过短)以及患者的不坚持和不遵守治疗方案导致的。其他原因包括氯菊酯的单一应用、建议将药物涂抹 6-8 小时、未能涂抹到甲皱襞、刺激性接触性皮炎,特别是在生殖器部位,一些患者因此停止治疗,以及不明原因地在疥疮后瘙痒症中使用氯菊酯。因此,我们认为,氯菊酯耐药的几个病例实际上是假性耐药的病例。